NU6140 is a selective inhibitor of CDK2-cyclin A (IC50, 0.41 μM). It shows 10- to 36-fold selectivity over other CDKs. NU6140 also effectively inhibits Aurora A and Aurora B (IC50s: 67 and 35 nM, respectively). It also enhances the apoptotic effect and has anti-cancer activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 106 | |
2 mg | In stock | $ 201 | |
4 mg | In stock | $ 270 | |
10 mg | In stock | $ 598 | |
20 mg | In stock | $ 902 |
Description | NU6140 is a selective inhibitor of CDK2-cyclin A (IC50, 0.41 μM). It shows 10- to 36-fold selectivity over other CDKs. NU6140 also effectively inhibits Aurora A and Aurora B (IC50s: 67 and 35 nM, respectively). It also enhances the apoptotic effect and has anti-cancer activity. |
Targets&IC50 | Aurora A:67 nM, Aurora B:35 nM, CDK5/p25:15 μM, CDK4/CyclinD:5.5 μM, CDK7/cyclinH:3.9 μM, CDK2/CyclinA:0.41 μM, CDK1/CyclinB:6.6 μM |
In vitro | NU6140 enhances catalytic activity of capase-9 and capase-3, causes an increase in the sub-G1 apoptotic cell population. NU6140 is less active on CDK1-cyclin B, CDK4-cyclin D, CDK5-p25 and CDK7-cyclin H (IC50s: 6.6, 5.5, 15 and 3.9 μM, respectively). |
CAS No. | 444723-13-1 |
Chemical Formula | C23H30N6O2 |
Molecular Weight | 422.533 |
Solubility | DMSO: 250 mg/mL (591.69 mM), Need ultrasonic |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom